Argenx Se (ARGX) Tax Rate (2017 - 2026)
Argenx Se (ARGX) posted quarterly Tax Rate of 33.09% for Q2 2026, down 421.0% year-on-year from 10.31% in Q2 2025, and up 341.53% on a QoQ basis from 13.7% in Q1 2026.
Argenx Se (ARGX) Tax Rate (2017 - 2026) Analysis & Trends
Argenx Se (ARGX) has reported Tax Rate for 10 consecutive years, with 33.09% the latest figure, recorded in Q2 2026.
- Quarterly Tax Rate fell 421.0% year-over-year to 33.09% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 10.91% (down 11096.0% YoY) and the FY2025 annual result came in at 1.05%, up 87693.0% from the prior year.
- Tax Rate grew to 33.09% in Q2 2026 per ARGX's latest filing, from 13.7% in the prior quarter.
- Over the last five years, Tax Rate for ARGX reached as high as 820.09% in Q4 2024 and fell as low as 293.73% in Q2 2024.
- A 5-year average of 55.57% and a median of 9.32% in 2022 frame the typical range for Tax Rate.
- The largest YoY upside for Tax Rate was 75798 bps in 2024 against a maximum downside of 30626 bps in 2024.
- Year by year, Tax Rate stood at 3.72% in 2022, then soared by 1570 bps to 62.1% in 2023, then jumped by 1221 bps to 820.09% in 2024, then sank by 95 bps to 37.3% in 2025, then fell by 11 bps to 33.09% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 33.09%, 13.7%, and 37.3% for Q2 2026, Q1 2026, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 7.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.09% |
| Jun 30, 2026 | 33.09% |
| Jun 30, 2026 | 33.09% |
| Mar 31, 2026 | -13.70% |
| Mar 31, 2026 | -13.70% |
| Mar 31, 2026 | -13.70% |
| Jun 30, 2025 | 37.30% |
| Jun 30, 2025 | 37.30% |
| Jun 30, 2025 | 37.30% |
| Mar 31, 2025 | -16.31% |
| Mar 31, 2025 | -16.31% |
| Mar 31, 2025 | -16.31% |
| Dec 31, 2024 | 820.09% |
| Dec 31, 2024 | 820.09% |
| Dec 31, 2024 | 820.09% |
| Jun 30, 2024 | -293.73% |
| Jun 30, 2024 | -293.73% |
| Jun 30, 2024 | -293.73% |
| Mar 31, 2024 | -46.47% |
| Mar 31, 2024 | -46.47% |